David Geldmacher
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research 45
- Schizophrenia research and treatment 5
- Neurology top 1%
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 11
- Physiology top 1%
- Alzheimer's disease research and treatments 17
- Developmental Neuroscience top 2%
-
- Health Systems, Economic Evaluations, Quality of Life 13
-
- Spatial Neglect and Hemispheric Dysfunction 9
-
- Cholinesterase and Neurodegenerative Diseases 9
-
- Geriatric Care and Nursing Homes 8
David Geldmacher
94 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Psychiatry and Mental health 1.9k
- Neurology 661
- Geriatrics and Gerontology 286
- Physiology 1.4k
- Developmental Neuroscience 210
Countries citing papers authored by David Geldmacher
This map shows the geographic impact of David Geldmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Geldmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Geldmacher more than expected).
Fields of papers citing papers by David Geldmacher
This network shows the impact of papers produced by David Geldmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Geldmacher. The network helps show where David Geldmacher may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Geldmacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 7 | |
| 4 | 2019 | 22 | |
| 5 | 2013 | 28 | |
| 6 | 2013 | 50 | |
| 7 | 2012 | 7 | |
| 8 | 2012 | 33 | |
| 9 | 2011 | 11 | |
| 10 | 2010 | 178 | |
| 11 | 2004 | 19 | |
| 12 | 2003 | 216 | |
| 13 | 2002 | 82 | |
| 14 | 2002 | 21 | |
| 15 | 1998 | 29 | |
| 16 | 1997 | 495 | |
| 17 | Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. | 1997 | 22 |
| 18 | Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. | 1997 | 2 |
| 19 | 1997 | 2 | |
| 20 | 1996 | 24 |
About David Geldmacher
David Geldmacher is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Family Practice, having authored 100 papers that have together received 4.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (45 papers), Alzheimer's disease research and treatments (17 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Spatial Neglect and Hemispheric Dysfunction (9 papers), Cholinesterase and Neurodegenerative Diseases (9 papers), Geriatric Care and Nursing Homes (8 papers) and Schizophrenia research and treatment (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.9k citations), Neurology (661 citations) and Geriatrics and Gerontology (286 citations). David Geldmacher has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Karl Herrup, Yanxu Yang, Peter J. Whitehouse, Richard C. Mohs, Steven H. Ferris, Michael Grundman, Mary Sano, Linas A. Bieliauskas, Milton E. Strauss and Susan D. Sperry. Their work appears in journals such as New England Journal of Medicine, Journal of Neuroscience and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.